Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad

REFERENCES

• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel diseases. Annu Rev Immunol 2010;28:573–621.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474(7351):298–306.
   PubMed Web of Science ®Google Scholar
• Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117(3):514–521.
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M, Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157(3):1261–1270.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Biancone L, Marasco R, Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112(4): 1169–1178.
   PubMed Web of Science ®Google Scholar
• Monteleone G, MacDonald TT. Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med 2000;32(8):552–560.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Hommes DW, Van Assche G, A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease. Gut 2006;55(8):1138–1144.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Mikhajlova TL, Stoinov S, Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut 2006;55(8):1131–1137.
   PubMed Web of Science ®Google Scholar
• Reinisch W, de Villiers W, Bene L, Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis 2010;16(2):233–242.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485–517.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453(7198):1051–1057.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139(3):485–498.
   PubMed Web of Science ®Google Scholar
• Salzman NH, Hung K, Haribhai D, Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11(1):76–83.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Nishimura J, Shima T, ATP drives lamina propria T(H)17 cell differentiation. Nature 2008;455(7214):808–812.
   PubMed Web of Science ®Google Scholar
• Hall JA, Bouladoux N, Sun CM, Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008;29(4):637–649.
   Google Scholar
• Hirota K, Turner JE, Villa M, Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 2013;14(4):372–379.
   Google Scholar
• Ivanov II, McKenzie BS, Zhou L. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126(6):1121–1133.
   PubMed Web of Science ®Google Scholar
• Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008;28(1):29–39.
   PubMed Web of Science ®Google Scholar
• Ciofani M, Madar A, Galan C, A validated regulatory network for Th17 cell specification. Cell 2012;151(2):289–303.
   PubMed Web of Science ®Google Scholar
• Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 2008;9(11): 1297–1306.
   PubMed Web of Science ®Google Scholar
• Sato K, Miyoshi F, Yokota K, Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development. J Biol Chem 2011;286(17):14963–14971.
   Google Scholar
• Zhou L, Ivanov II, Spolski R, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8(9):967–974.
   PubMed Web of Science ®Google Scholar
• Maggi L, Santarlasci V, Capone M, CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 2010;40(8):2174–2181.
   PubMed Web of Science ®Google Scholar
• Martin B, Hirota K, Cua DJ, Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009;31(2):321–330.
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52(1):65–70.
   PubMed Web of Science ®Google Scholar
• Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12(1):21–27.
   PubMed Web of Science ®Google Scholar
• Seiderer J, Elben I, Diegelmann J, Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008;14(4):437–445.
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T, IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006;290(4):G827–G838.
   PubMed Web of Science ®Google Scholar
• Dambacher J, Beigel F, Zitzmann K, The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2009;58(9):1207–1217.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Boniface K, Sadekova S, Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009;206(3):525–534.
   PubMed Web of Science ®Google Scholar
• Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011;140(3):957–965.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blumenschein WM, Brovont-Porth K, Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J Immunol 2010;185(1):679–687.
   PubMed Web of Science ®Google Scholar
• Volpe E, Servant N, Zollinger R, A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008;9(6):650–657.
   PubMed Web of Science ®Google Scholar
• Lee YK, Turner H, Maynard CL, Late developmental plasticity in the T helper 17 lineage. Immunity 2009;30(1):92–107.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Kumberova A, Croft NM, Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001;108(4):601–609.
   PubMed Web of Science ®Google Scholar
• Zorzi F, Monteleone I, Sarra M, Distinct profiles of effector cytokines mark the different phases of Crohn's disease. PLoS One 2013;8(1):e54562.
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G, Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007;448(7152):480–483.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W, IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007;448(7152):484–487.
   PubMed Web of Science ®Google Scholar
• Fina D, Sarra M, Fantini MC, Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 2008;134(4):1038–1048.
   PubMedGoogle Scholar
• Sarra M, Monteleone I, Stolfi C, Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis 2010;16(8):1332–1339.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Monteleone I, Fina D, Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology. 2005;128(3):687–694.
   Google Scholar
• Jovanovic DV, Di Battista JA, Martel-Pelletier J, IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160(7):3513–3521.
   PubMed Web of Science ®Google Scholar
• Ye P, Rodriguez FH, Kanaly S, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194(4):519–527.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6(11):1133–1141.
   PubMed Web of Science ®Google Scholar
• Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495–549.
   PubMed Web of Science ®Google Scholar
• Ogawa A, Andoh A, Araki Y, Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004;110(1):55–62.
   PubMed Web of Science ®Google Scholar
• Yang XO, Chang SH, Park H, Regulation of inflammatory responses by IL-17F. J Exp Med 2008;205(5):1063–1075.
   PubMed Web of Science ®Google Scholar
• Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000;118(6):1001–1011.
   PubMed Web of Science ®Google Scholar
• Medina-Contreras O, Geem D, Laur O, CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest 2011;121(12): 4787–4795.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zheng M, Bindas J, et al. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006;12(5):382–388.
   PubMed Web of Science ®Google Scholar
• Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14(2):155–174.
   PubMed Web of Science ®Google Scholar
• Chaudhry A, Rudra D, Treuting P, CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009;326(5955):986–991.
   Web of Science ®Google Scholar
• Elson CO, Cong Y, Weaver CT, Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007;132(7):2359–2370.
   PubMed Web of Science ®Google Scholar
• Leppkes M, Becker C, Ivanov II, RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136(1): 257–267.
   PubMed Web of Science ®Google Scholar
• Noguchi D, Wakita D, Tajima M, Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner. Int Immunol 2007;19(12):1431–1440.
   PubMed Web of Science ®Google Scholar
• O'Connor W Jr, Kamanaka M, Booth CJ, A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009;10(6):603–609.
   PubMed Web of Science ®Google Scholar
• Pan HF, Li XP, Zheng SG, Ye DQ. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev 2013;24(1):51–57
   PubMed Web of Science ®Google Scholar
• Monteleone I, MacDonald TT, Pallone F, Monteleone G. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis. Curr Opin Gastroenterol 2012;28(4):310–313
   Google Scholar
• Zheng Y, Valdez PA, Danilenko DM, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14(3):282–289.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ogawa A, Mizoguchi E, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118(2):534–544.
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29(6):947–957.
   PubMed Web of Science ®Google Scholar
• Trifari S, Kaplan CD, Tran EH, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009;10(8):864–871.
   PubMed Web of Science ®Google Scholar
• Monteleone I, Rizzo A, Sarra M, Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011;141(1): 237–248, 248.e1.
   PubMed Web of Science ®Google Scholar
• Hueber W, Sands BE, Lewitzky S, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012;61(12):1693–1700.
   PubMed Web of Science ®Google Scholar
• Mannon PJ, Fuss IJ, Mayer L, Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 2004;351(20):2069–2079.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG, Fedorak RN, A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008;135(4):1130–1141.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Gasink C, Gao LL, Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012;367(16):1519–1528.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Bak-Jensen KS, Chen Y, TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007;8(12):1390–1397.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314(5804):1461–1463.
   PubMed Web of Science ®Google Scholar
• Pidasheva S, Trifari S, Phillips A, Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One 2011;6(10):e25038.
   PubMed Web of Science ®Google Scholar